70 related articles for article (PubMed ID: 8466856)
21. Suppression of malignant growth potentials of v-Src-transformed human gallbladder epithelial cells by adenovirus-mediated dominant negative H-Ras.
Tokumitsu Y; Nakano S; Ueno H; Niho Y
J Cell Physiol; 2000 May; 183(2):221-7. PubMed ID: 10737897
[TBL] [Abstract][Full Text] [Related]
22. p53-independent tumor growth and in vitro cell survival for F-MuLV-induced erythroleukemias.
Howard J; Ung Y; Adachi D; Ben-David Y
Cell Growth Differ; 1996 Dec; 7(12):1651-60. PubMed ID: 8959333
[TBL] [Abstract][Full Text] [Related]
23. Cooperation of TGF alpha and c-Myc in mouse mammary tumorigenesis: coordinated stimulation of growth and suppression of apoptosis.
Amundadottir LT; Nass SJ; Berchem GJ; Johnson MD; Dickson RB
Oncogene; 1996 Aug; 13(4):757-65. PubMed ID: 8761297
[TBL] [Abstract][Full Text] [Related]
24. Reexpression of the major protein kinase C substrate, SSeCKS, suppresses v-src-induced morphological transformation and tumorigenesis.
Lin X; Gelman IH
Cancer Res; 1997 Jun; 57(11):2304-12. PubMed ID: 9187136
[TBL] [Abstract][Full Text] [Related]
25. Coordinate up-regulation of hypoxia inducible factor (HIF)-1alpha and HIF-1 target genes during multi-stage epidermal carcinogenesis and wound healing.
Elson DA; Ryan HE; Snow JW; Johnson R; Arbeit JM
Cancer Res; 2000 Nov; 60(21):6189-95. PubMed ID: 11085544
[TBL] [Abstract][Full Text] [Related]
26. Reduced growth capacity of hepatocytes from c-myc and c-myc/TGF-alpha transgenic mice in primary culture.
Kao CY; Factor VM; Thorgeirsson SS
Biochem Biophys Res Commun; 1996 May; 222(1):64-70. PubMed ID: 8630075
[TBL] [Abstract][Full Text] [Related]
27. Enhanced proliferation, apoptosis, and matrix accumulation by mesangial cells derived from HIV-1 transgenic mice.
Singhal PC; Sharma P; Loona R; Gibbons N; Franki N; Klotman PE
J Investig Med; 1998 Aug; 46(6):297-302. PubMed ID: 9737092
[TBL] [Abstract][Full Text] [Related]
28. Detection of amphiregulin and Cripto-1 in mammary tumors from transgenic mice.
Kenney NJ; Smith GH; Maroulakou IG; Green JH; Muller WJ; Callahan R; Salomon DS; Dickson RB
Mol Carcinog; 1996 Jan; 15(1):44-56. PubMed ID: 8561865
[TBL] [Abstract][Full Text] [Related]
29. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.
Gehling UM; Ryder JW; Hogan CJ; Hami L; McNiece I; Franklin W; Williams S; Helm K; King J; Shpall EJ
Exp Hematol; 1997 Oct; 25(11):1125-39. PubMed ID: 9328449
[TBL] [Abstract][Full Text] [Related]
30. Effect of decreased fte-1 gene expression on protein synthesis, cell growth, and transformation.
Kho CJ; Wang Y; Zarbl H
Cell Growth Differ; 1996 Sep; 7(9):1157-66. PubMed ID: 8877097
[TBL] [Abstract][Full Text] [Related]
31. Transforming growth factor-beta isoforms differently stimulate proalpha2 (I) collagen gene expression during wound healing process in transgenic mice.
Kinbara T; Shirasaki F; Kawara S; Inagaki Y; de Crombrugghe B; Takehara K
J Cell Physiol; 2002 Mar; 190(3):375-81. PubMed ID: 11857453
[TBL] [Abstract][Full Text] [Related]
32. Transgenic coexpression of v-Ha-ras and transforming growth factor alpha increases epidermal hyperproliferation and tumorigenesis and predisposes to malignant conversion via endogenous c-Ha-ras activation.
Wang XJ; Greenhalgh DA; Roop DR
Mol Carcinog; 2000 Mar; 27(3):200-9. PubMed ID: 10708482
[TBL] [Abstract][Full Text] [Related]
33. Loss of differentiation control in transformed 3T3 T proadipocytes.
Sparks RL; Allen BJ; Zygmunt AI; Strauss EE
Cancer Res; 1993 Apr; 53(8):1770-6. PubMed ID: 8467495
[TBL] [Abstract][Full Text] [Related]
34. Altered Ets transcription factor activity in prostate tumor cells inhibits anchorage-independent growth, survival, and invasiveness.
Foos G; Hauser CA
Oncogene; 2000 Nov; 19(48):5507-16. PubMed ID: 11114728
[TBL] [Abstract][Full Text] [Related]
35. Directed mutation of the basic domain of v-Jun alters DNA binding specificity and abolishes its oncogenic activity in chicken embryo fibroblasts.
Basso J; Briggs J; Findlay C; Bos T
Oncogene; 2000 Oct; 19(42):4876-85. PubMed ID: 11039905
[TBL] [Abstract][Full Text] [Related]
36. Integrin alpha 11 regulates IGF2 expression in fibroblasts to enhance tumorigenicity of human non-small-cell lung cancer cells.
Zhu CQ; Popova SN; Brown ER; Barsyte-Lovejoy D; Navab R; Shih W; Li M; Lu M; Jurisica I; Penn LZ; Gullberg D; Tsao MS
Proc Natl Acad Sci U S A; 2007 Jul; 104(28):11754-9. PubMed ID: 17600088
[TBL] [Abstract][Full Text] [Related]
37. Down-regulation of the extracellular matrix protein SPARC in vSrc- and vJun-transformed chick embryo fibroblasts contributes to tumor formation in vivo.
Vial E; Castellazzi M
Oncogene; 2000 Mar; 19(14):1772-82. PubMed ID: 10777211
[TBL] [Abstract][Full Text] [Related]
38. WAP-TAg transgenic mice and the study of dysregulated cell survival, proliferation, and mutation during breast carcinogenesis.
Li M; Lewis B; Capuco AV; Laucirica R; Furth PA
Oncogene; 2000 Feb; 19(8):1010-9. PubMed ID: 10713684
[TBL] [Abstract][Full Text] [Related]
39. Human ornithine decarboxylase-overproducing NIH3T3 cells induce rapidly growing, highly vascularized tumors in nude mice.
Auvinen M; Laine A; Paasinen-Sohns A; Kangas A; Kangas L; Saksela O; Andersson LC; Hölttä E
Cancer Res; 1997 Jul; 57(14):3016-25. PubMed ID: 9230217
[TBL] [Abstract][Full Text] [Related]
40. Regulatory imbalances in cell proliferation and cell death during oncogenesis in transgenic mice.
Merlino G
Semin Cancer Biol; 1994 Feb; 5(1):13-20. PubMed ID: 8186384
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
